Biotech Takeover Targets Wall Street Eyes After Apogee Deal
AbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Looking for quick-paying work from home jobs? Explore opportunities that allow you to earn fast from home.
20,735 articlesAbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Inflation just 3-year high is reshaping everyday costs and the profit path for credit card lenders. This guide explai...
A massive AI spending wave among hyperscalers could redefine markets. Discover why billionaire Bill Ackman is placing...
A high-profile hedge fund reveals a fresh stake in Clearwater Analytics, the investment accounting platform. We break...
Oracle posted a strong top line for fiscal Q3 2026, but a ballooning capex bill pushed free cash flow deep into negat...
A volatile market mood meets a high-stakes regulatory backdrop. This guide unpacks how to evaluate the latest super m...
Investors are watching Lyft’s 2026 earnings closely to see if core growth, cost discipline, and smarter incentives ca...
AuthID is building the identity layer for the digital economy. This piece breaks down what to expect from authid (aui...
When rates rise, bank stocks can outperform. This guide reveals why the Invesco KBW Bank ETF (KBWB) may be the smarte...
An independent analysis released this week shows nearly half u.s. families couldn't cover basic necessities in 2024, ...
PayPal used to attract a premium multiple, but the growth narrative has cooled. This article breaks down the data, co...
As markets swing in 2026, credit score milestones continue to shape loan terms and funding access. This report explai...